Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Sep;101(3):487–493. doi: 10.1111/j.1365-2249.1995.tb03139.x

Depression in caregivers of demented patients is associated with altered immunity: impaired proliferative capacity, increased CD8+, and a decline in lymphocytes with surface signal transduction molecules (CD38+) and a cytotoxicity marker (CD56+ CD8+).

S Castle 1, S Wilkins 1, E Heck 1, K Tanzy 1, J Fahey 1
PMCID: PMC1553232  PMID: 7545096

Abstract

Changes in relevant immune parameters, including function, were found to be associated with depression in elderly caregiver wives of demented patients. We studied the relationship between immune cell phenotype and T cell proliferative capacity of such caregivers to levels of stress and depression over the course of a support group intervention. The data indicate the strongest association between depression (of all stress parameters) and impaired T cell proliferative capacity. Depression was also most strongly (of stress parameters) associated with a shift in T cell populations with an increase in CD8+ T cells, and a reduced percentage of CD38+ cells in both CD8+ and CD4+ T cell populations. Since CD38 is a signal transduction factor, it was interesting that a decreased percentage of CD38+ cells correlated with impaired T cell function (proliferation). Another significant difference was the reduction in natural killer (NK) cells as well as the percentage of the CD56+ component of the CD8+ population. This latter subset is important in MHC-unrestricted cytotoxicity, and has been found expanded in healthy centenarians. This study shows that both chronic stress, and depression in particular, and age have deleterious effects on T cells, and together could significantly contribute to the higher risk of disease and mortality associated with being a caregiver of a demented individual.

Full text

PDF
492

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Eliyahu S., Yirmiya R., Liebeskind J. C., Taylor A. N., Gale R. P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun. 1991 Jun;5(2):193–205. doi: 10.1016/0889-1591(91)90016-4. [DOI] [PubMed] [Google Scholar]
  2. Burack J. H., Barrett D. C., Stall R. D., Chesney M. A., Ekstrand M. L., Coates T. J. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men. JAMA. 1993 Dec 1;270(21):2568–2573. [PubMed] [Google Scholar]
  3. Cossarizza A., Ortolani C., Forti E., Montagnani G., Paganelli R., Zannotti M., Marini M., Monti D., Franceschi C. Age-related expansion of functionally inefficient cells with markers of natural killer activity in Down's syndrome. Blood. 1991 Mar 15;77(6):1263–1270. [PubMed] [Google Scholar]
  4. Dupuy d'Angeac A., Monier S., Jorgensen C., Gao Q., Travaglio-Encinoza A., Bologna C., Combe B., Sany J., Rème T. Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. Arthritis Rheum. 1993 May;36(5):608–612. doi: 10.1002/art.1780360506. [DOI] [PubMed] [Google Scholar]
  5. Erkeller-Yuksel F. M., Deneys V., Yuksel B., Hannet I., Hulstaert F., Hamilton C., Mackinnon H., Stokes L. T., Munhyeshuli V., Vanlangendonck F. Age-related changes in human blood lymphocyte subpopulations. J Pediatr. 1992 Feb;120(2 Pt 1):216–222. doi: 10.1016/s0022-3476(05)80430-5. [DOI] [PubMed] [Google Scholar]
  6. Evans D. L., Pedersen C. A., Folds J. D. Major depression and immunity: preliminary evidence of decreased natural killer cell populations. Prog Neuropsychopharmacol Biol Psychiatry. 1988;12(5):739–748. doi: 10.1016/0278-5846(88)90019-x. [DOI] [PubMed] [Google Scholar]
  7. Funaro A., Spagnoli G. C., Ausiello C. M., Alessio M., Roggero S., Delia D., Zaccolo M., Malavasi F. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol. 1990 Oct 15;145(8):2390–2396. [PubMed] [Google Scholar]
  8. Glaser R., Kennedy S., Lafuse W. P., Bonneau R. H., Speicher C., Hillhouse J., Kiecolt-Glaser J. K. Psychological stress-induced modulation of interleukin 2 receptor gene expression and interleukin 2 production in peripheral blood leukocytes. Arch Gen Psychiatry. 1990 Aug;47(8):707–712. doi: 10.1001/archpsyc.1990.01810200015002. [DOI] [PubMed] [Google Scholar]
  9. Glaser R., Rice J., Speicher C. E., Stout J. C., Kiecolt-Glaser J. K. Stress depresses interferon production by leukocytes concomitant with a decrease in natural killer cell activity. Behav Neurosci. 1986 Oct;100(5):675–678. doi: 10.1037//0735-7044.100.5.675. [DOI] [PubMed] [Google Scholar]
  10. Guidi L., Bartoloni C., Frasca D., Antico L., Pili R., Cursi F., Tempesta E., Rumi C., Menini E., Carbonin P. Impairment of lymphocyte activities in depressed aged subjects. Mech Ageing Dev. 1991 Sep;60(1):13–24. doi: 10.1016/0047-6374(91)90105-9. [DOI] [PubMed] [Google Scholar]
  11. Heo D. S., Whiteside T. L., Kanbour A., Herberman R. B. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors. J Immunol. 1988 Jun 1;140(11):4042–4049. [PubMed] [Google Scholar]
  12. Howard M., Grimaldi J. C., Bazan J. F., Lund F. E., Santos-Argumedo L., Parkhouse R. M., Walseth T. F., Lee H. C. Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science. 1993 Nov 12;262(5136):1056–1059. doi: 10.1126/science.8235624. [DOI] [PubMed] [Google Scholar]
  13. Irwin M. Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production. Endocrinology. 1993 Sep;133(3):1352–1360. doi: 10.1210/endo.133.3.8365372. [DOI] [PubMed] [Google Scholar]
  14. Irwin M., Brown M., Patterson T., Hauger R., Mascovich A., Grant I. Neuropeptide Y and natural killer cell activity: findings in depression and Alzheimer caregiver stress. FASEB J. 1991 Dec;5(15):3100–3107. doi: 10.1096/fasebj.5.15.1743441. [DOI] [PubMed] [Google Scholar]
  15. Irwin M., Smith T. L., Gillin J. C. Low natural killer cytotoxicity in major depression. Life Sci. 1987 Nov 2;41(18):2127–2133. doi: 10.1016/0024-3205(87)90531-5. [DOI] [PubMed] [Google Scholar]
  16. Irwin M. Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms. Adv Neuroimmunol. 1994;4(1):29–47. doi: 10.1016/s0960-5428(06)80188-9. [DOI] [PubMed] [Google Scholar]
  17. Kennedy S., Kiecolt-Glaser J. K., Glaser R. Immunological consequences of acute and chronic stressors: mediating role of interpersonal relationships. Br J Med Psychol. 1988 Mar;61(Pt 1):77–85. doi: 10.1111/j.2044-8341.1988.tb02766.x. [DOI] [PubMed] [Google Scholar]
  18. Kiecolt-Glaser J. K., Glaser R., Shuttleworth E. C., Dyer C. S., Ogrocki P., Speicher C. E. Chronic stress and immunity in family caregivers of Alzheimer's disease victims. Psychosom Med. 1987 Sep-Oct;49(5):523–535. doi: 10.1097/00006842-198709000-00008. [DOI] [PubMed] [Google Scholar]
  19. Labalette M., Salez F., Pruvot F. R., Noel C., Dessaint J. P. CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57- subset and its progressive replacement by CD8+ CD57+ T cells. Clin Exp Immunol. 1994 Mar;95(3):465–471. doi: 10.1111/j.1365-2249.1994.tb07020.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Landay A. L., Jessop C., Lennette E. T., Levy J. A. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet. 1991 Sep 21;338(8769):707–712. doi: 10.1016/0140-6736(91)91440-6. [DOI] [PubMed] [Google Scholar]
  21. Lee H. C., Walseth T. F., Bratt G. T., Hayes R. N., Clapper D. L. Structural determination of a cyclic metabolite of NAD+ with intracellular Ca2+-mobilizing activity. J Biol Chem. 1989 Jan 25;264(3):1608–1615. [PubMed] [Google Scholar]
  22. Levacher M., Hulstaert F., Tallet S., Ullery S., Pocidalo J. J., Bach B. A. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clin Exp Immunol. 1992 Dec;90(3):376–382. doi: 10.1111/j.1365-2249.1992.tb05854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Lu P. H., Negrin R. S. A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol. 1994 Aug 15;153(4):1687–1696. [PubMed] [Google Scholar]
  24. Malavasi F., Funaro A., Alessio M., DeMonte L. B., Ausiello C. M., Dianzani U., Lanza F., Magrini E., Momo M., Roggero S. CD38: a multi-lineage cell activation molecule with a split personality. Int J Clin Lab Res. 1992;22(2):73–80. doi: 10.1007/BF02591400. [DOI] [PubMed] [Google Scholar]
  25. Malavasi F., Funaro A., Roggero S., Horenstein A., Calosso L., Mehta K. Human CD38: a glycoprotein in search of a function. Immunol Today. 1994 Mar;15(3):95–97. doi: 10.1016/0167-5699(94)90148-1. [DOI] [PubMed] [Google Scholar]
  26. Miller R. A. Aging and immune function. Int Rev Cytol. 1991;124:187–215. doi: 10.1016/s0074-7696(08)61527-2. [DOI] [PubMed] [Google Scholar]
  27. Mitropoulos D., Kooi S., Rodriguez-Villanueva J., Platsoucas C. D. Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma. Clin Exp Immunol. 1994 Aug;97(2):321–327. doi: 10.1111/j.1365-2249.1994.tb06088.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Monjan A. A., Collector M. I. Stress-induced modulation of the immune response. Science. 1977 Apr 15;196(4287):307–308. doi: 10.1126/science.557841. [DOI] [PubMed] [Google Scholar]
  29. Prince H. E., Bermudez S., Plaeger-Marshall S. Preparation of CD8bright and CD8dim lymphocyte populations using two positive selection methods in tandem. J Immunol Methods. 1993 Oct 15;165(2):139–148. doi: 10.1016/0022-1759(93)90339-9. [DOI] [PubMed] [Google Scholar]
  30. Sadat-Sowti B., Parrot A., Quint L., Mayaud C., Debre P., Autran B. Alveolar CD8+CD57+ lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am J Respir Crit Care Med. 1994 Apr;149(4 Pt 1):972–980. doi: 10.1164/ajrccm.149.4.7511468. [DOI] [PubMed] [Google Scholar]
  31. Sansoni P., Cossarizza A., Brianti V., Fagnoni F., Snelli G., Monti D., Marcato A., Passeri G., Ortolani C., Forti E. Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians. Blood. 1993 Nov 1;82(9):2767–2773. [PubMed] [Google Scholar]
  32. Schleifer S. J., Keller S. E., Bond R. N., Cohen J., Stein M. Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization. Arch Gen Psychiatry. 1989 Jan;46(1):81–87. doi: 10.1001/archpsyc.1989.01810010083011. [DOI] [PubMed] [Google Scholar]
  33. Schleifer S. J., Keller S. E., Camerino M., Thornton J. C., Stein M. Suppression of lymphocyte stimulation following bereavement. JAMA. 1983 Jul 15;250(3):374–377. [PubMed] [Google Scholar]
  34. Strausbaugh H., Irwin M. Central corticotropin-releasing hormone reduces cellular immunity. Brain Behav Immun. 1992 Mar;6(1):11–17. doi: 10.1016/0889-1591(92)90055-s. [DOI] [PubMed] [Google Scholar]
  35. Wang E. C., Taylor-Wiedeman J., Perera P., Fisher J., Borysiewicz L. K. Subsets of CD8+, CD57+ cells in normal, healthy individuals: correlations with human cytomegalovirus (HCMV) carrier status, phenotypic and functional analyses. Clin Exp Immunol. 1993 Nov;94(2):297–305. doi: 10.1111/j.1365-2249.1993.tb03447.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Watret K. C., Whitelaw J. A., Froebel K. S., Bird A. G. Phenotypic characterization of CD8+ T cell populations in HIV disease and in anti-HIV immunity. Clin Exp Immunol. 1993 Apr;92(1):93–99. doi: 10.1111/j.1365-2249.1993.tb05953.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Yagi M. J., Joesten M. E., Wallace J., Roboz J. P., Bekesi J. G. Human immunodeficiency virus type 1 (HIV-1) genomic sequences and distinct changes in CD8+ lymphocytes precede detectable levels of HIV-1 antibodies in high-risk homosexuals. J Infect Dis. 1991 Jul;164(1):183–188. doi: 10.1093/infdis/164.1.183. [DOI] [PubMed] [Google Scholar]
  38. Yesavage J. A., Brink T. L., Rose T. L., Lum O., Huang V., Adey M., Leirer V. O. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49. doi: 10.1016/0022-3956(82)90033-4. [DOI] [PubMed] [Google Scholar]
  39. Zisook S., Shuchter S. R., Irwin M., Darko D. F., Sledge P., Resovsky K. Bereavement, depression, and immune function. Psychiatry Res. 1994 Apr;52(1):1–10. doi: 10.1016/0165-1781(94)90114-7. [DOI] [PubMed] [Google Scholar]
  40. van Rood Y., Goulmy E., Blokland E., Pool J., van Rood J., van Houwelingen H. Month-related variability in immunological test results; implications for immunological follow-up studies. Clin Exp Immunol. 1991 Nov;86(2):349–354. doi: 10.1111/j.1365-2249.1991.tb05821.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES